Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug targeting by solid lipid nanoparticles for dermal use.

C Santos Maia1, W Mehnert, M Schaller

  • 1Department of Pharmacy (Pharmacology and Toxicology), Freie Universität Berlin, Königin-Luise-Str. 2+4, 14195 Berlin, Germany.

Journal of Drug Targeting
|February 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toxicity of topically applied drugs beyond skin irritation: Static skin model vs. Two organs-on-a-chip.

International journal of pharmaceutics·2020
Same author

Enhanced topical delivery of dexamethasone by β-cyclodextrin decorated thermoresponsive nanogels.

Nanoscale·2017
Same author

Triple-combination therapy in the treatment of hypertension: a review of the evidence.

Journal of human hypertension·2017
Same author

Influence of the skin barrier on the penetration of topically-applied dexamethasone probed by soft X-ray spectromicroscopy.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2016
Same author

Core-multishell nanocarriers: Transport and release of dexamethasone probed by soft X-ray spectromicroscopy.

Journal of controlled release : official journal of the Controlled Release Society·2016
Same author

Catch-up validation study of an in vitro skin irritation test method based on an open source reconstructed epidermis (phase II).

Toxicology in vitro : an international journal published in association with BIBRA·2016

New lipid nanoparticles enhance topical drug delivery by targeting the epidermis, reducing the risk of skin atrophy associated with long-term glucocorticoid use. This approach improves the benefit-risk ratio of topical therapies.

Area of Science:

  • Dermatology
  • Nanotechnology
  • Pharmacology

Background:

  • Long-term topical glucocorticoid use can cause skin atrophy by inhibiting fibroblasts.
  • Novel drug delivery systems are needed to reduce this risk through epidermal targeting.

Purpose of the Study:

  • To evaluate prednicarbate (PC) incorporated into solid lipid nanoparticles for enhanced epidermal targeting.
  • To assess the potential of these nanoparticles to mitigate glucocorticoid-induced skin atrophy.

Main Methods:

  • Prednicarbate (0.25%) was formulated into solid lipid nanoparticles.
  • Drug penetration and metabolism were studied in excised human skin and reconstructed epidermis.
  • Comparisons were made with conventional PC cream and ointment.

Related Experiment Videos

Main Results:

  • Nanoparticle dispersion showed significantly higher drug recovery (6.65%) compared to cream/ointment (2%) in the acceptor medium.
  • PC-loaded nanoparticles demonstrated a localizing effect in the epidermal layer, peaking at 6 hours.
  • The targeting effect was linked to PC-nanoparticles, not drug-free nanoparticles or lipid composition.

Conclusions:

  • Lipid nanoparticle-induced epidermal targeting of prednicarbate offers a promising strategy.
  • This approach may improve the benefit-risk ratio of topical glucocorticoid therapy.
  • Further research into nanoparticle-based drug delivery for dermatological conditions is warranted.